Compare PCG & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCG | ALC |
|---|---|---|
| Founded | 1995 | 1945 |
| Country | United States | Switzerland |
| Employees | 29000 | N/A |
| Industry | Power Generation | Ophthalmic Goods |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.0B | 32.4B |
| IPO Year | N/A | 2002 |
| Metric | PCG | ALC |
|---|---|---|
| Price | $17.10 | $69.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 12 |
| Target Price | $22.19 | ★ $89.38 |
| AVG Volume (30 Days) | ★ 17.5M | 1.8M |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.22% | 0.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $7.24 | $7.99 |
| Revenue Next Year | $3.41 | $6.38 |
| P/E Ratio | ★ $15.15 | $38.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.97 | $61.84 |
| 52 Week High | $19.16 | $92.55 |
| Indicator | PCG | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 54.88 | 58.86 |
| Support Level | $17.00 | $63.91 |
| Resistance Level | $18.94 | $82.09 |
| Average True Range (ATR) | 0.33 | 1.29 |
| MACD | 0.02 | 0.41 |
| Stochastic Oscillator | 68.20 | 98.63 |
PG&E is a holding company whose main subsidiary is Pacific Gas and Electric, a regulated utility operating in Central and Northern California that serves 5.3 million electricity customers and 4.6 million gas customers in 47 of the state's 58 counties. PG&E operated under bankruptcy court supervision in 2001-04 during California's energy crisis and in 2019-20 due to wildfire losses. In 2004, PG&E sold its unregulated assets as part of its first postbankruptcy reorganization.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.